Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Clinical trial NCT02059278 · COMPLETED
Trial details
- NCT number
- NCT02059278
- Sponsor
- Nephron Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-01-01
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.